US OptionsDetailed Quotes
RIGL241220C11000
- 3.40
- 0.000.00%
15min DelayTrading Oct 25 15:53 ET
0.00High0.00Low
0.00Open3.40Pre Close0 Volume2 Open Interest11.00Strike Price0.00Turnover583.36%IV-24.88%PremiumDec 20, 2024Expiry Date8.17Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8869Delta0.0162Gamma2.12Leverage Ratio-0.2827Theta0.0009Rho1.88Eff Leverage0.0039Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet